SCHEMBL288415

SCHEMBL288415

N[C@@H](CS)CCC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1267944 1.00
SCHEMBL1267942 1.00
SCHEMBL28919596 0.86 ENPEP (1.00)
SCHEMBL289090 0.84 ENPEP (0.76)
SCHEMBL288271 0.83 ENPEP (1.00)
SCHEMBL1878207 0.83 ENPEP (1.00)
SCHEMBL1878208 0.83 ENPEP (1.00)
SCHEMBL289102 0.77 ENPEP (0.62)
SCHEMBL288129 0.77 ENPEP (0.62)
SCHEMBL289109 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4368208-A2 NOVEL HYALURONIC ACID-BASED HYDROGELS HAVING MEDICAL APPLICATIONS The Regents of University of California (US) 2024-05-15 EP claimed
US-10017481-B2 Conformationally constrained, fully synthetic macrocyclic compounds POLYPHOR AG (CH) 2018-07-10 US claimed
US-20180186900-A1 Novel Hyaluronic Acid-Based Hydrogels Having Medical Applications UNIV CALIFORNIA (US) 2018-07-05 US claimed
EP-3307338-A1 NOVEL HYALURONIC ACID-BASED HYDROGELS HAVING MEDICAL APPLICATIONS The Regents of The University of California (US) 2018-04-18 EP claimed
EP-2836485-B1 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS POLYPHOR AG (CH) 2018-01-10 EP claimed
US-9695191-B2 Conformationally constrained, fully synthetic macrocyclic compounds POLYPHOR AG (CH) 2017-07-04 US claimed
EP-2499148-B1 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS POLYPHOR AG (CH) 2017-01-18 EP claimed
WO-2016201382-A1 NOVEL HYALURONIC ACID-BASED HYDROGELS HAVING MEDICAL APPLICATIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2016-12-15 WO claimed
US-9512139-B2 Conformationally constrained, fully synthetic macrocyclic compounds POLYPHOR AG (CH) 2016-12-06 US claimed
US-20150051183-A1 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS POLYPHOR AG (CH) 2015-02-19 US claimed
EP-2836485-A1 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS Polyphor Ag (CH) 2015-02-18 EP claimed
EP-2462147-B1 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS POLYPHOR AG (CH) 2014-11-12 EP claimed
US-20140112976-A1 Cyclic Peptides with an Anti-Neoplasic and Anti-Angiogenic Activity CENTRO DE INGENIERIA GENETICA BIOTECNOLOGIA (CU) 2014-04-24 US claimed
EP-2690107-A2 CYCLIC PEPTIDES WITH AN ANTI-NEOPLASIC AND ANTI-ANGIOGENIC ACTIVITY Centro De Ingenieria Genetica Y Biotecnologia (CU) 2014-01-29 EP claimed
CN-103534265-A Cyclic peptides with an anti-neoplasic and anti-angiogenic activity CT INGENIERIA GENETICA BIOTECH 2014-01-22 CN claimed
WO-2013139697-A1 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS POLYPHOR AG (CH) 2013-09-26 WO claimed
US-20120270881-A1 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS POLYPHOR AG (CH) 2012-10-25 US claimed
EP-2499148-A2 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS Polyphor Ag (CH) 2012-09-19 EP claimed
US-20120202821-A1 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS POLYPHOR AG (CH) 2012-08-09 US claimed
WO-2011014973-A2 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS POLYPHOR AG (CH) 2011-02-10 WO claimed